Simpler Grants.gov #PAR-25-266

NIH Grant for Innovative Newborn Screening and Therapies Research

This opportunity seeks research proposals from a broad range of organizations to advance newborn screening and therapies for serious genetic conditions. - Government Buyer: - National Institutes of Health (NIH) - OEMs and Vendors: - National Institutes of Health (NIH) is the only agency and funding source mentioned - Products/Services Requested: - Research projects focused on developing innovative screening methods and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening - Includes high priority genetic conditions where screening may soon be feasible - No specific products, part numbers, or purchase quantities are listed, as this is a research grant - Unique or Notable Requirements: - Open to a wide range of eligible applicants: government entities, nonprofits, educational institutions, businesses, and other organizations - Projects should advance accurate screening tests and demonstrate the benefits of early intervention or treatment - Clinical trial component is optional - Focus on research that supports inclusion of new conditions in newborn screening panels

Description

This funding opportunity announcement (FOA) encourages research focused on developing novel screening methods and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening. It also targets "high priority" genetic conditions where screening may soon be feasible. The FOA emphasizes the importance of accurate screening tests and demonstrating the benefits of early intervention or treatment for inclusion in newborn screening panels. Eligible applicants include various government entities, nonprofits, educational institutions, businesses, and other organizations.

View original listing